Officer/Director Transaction Filing

Lisa Egbuonu-Davis, a director at AVANOS MEDICAL, INC. (AVNS), acquired 12,003 Restricted Share Units (RSUs) on May 8, 2026. These RSUs, which represent a contingent right to receive a cash payment equivalent to the value of one share of AVNS common stock, were issued to replace previously granted RSUs. The RSUs vest upon Ms. Egbuonu-Davis's termination of service on the board. The transaction was reported on May 12, 2026.